Mianserin

  • TRADE NAMES: Athimil (Hormoquimica); Bolvidon (Schering-Plough, GSK); Lantanon (Schering-Plough); Lerivon (Schering-Plough); Miaxan (Orion); Norval (Schering-Plough, GSK); Tetramide (Daiichi Sankyo); Tolvon (Schering-Plough)
  • INDICATIONS: Depression
  • CLASS: Antidepressant; tetracyclic
  • HALF-LIFE: 10 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Codeine, Diazepam, Morphine, Temazepam, Zopiclone

Our database has 4 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
NEUROMUSCULAR/SKELETAL.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top